A Phase II Study in Patients With Alopecia Areata

PHASE2CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

May 13, 2020

Primary Completion Date

June 10, 2021

Study Completion Date

June 29, 2021

Conditions
Alopecia Areata
Interventions
DRUG

SHR0302

Oral tablets taken once daily (QD)

Trial Locations (34)

2217

St George Dermatology and Skin Cancer Centre, Kogarah

2289

Novatrials, Kogarah

3002

Sinclair Dermatology, East Melbourne

Sinclair Dermatology, Melbourne

3053

Skin Health Institute, Carlton

4102

Veracity Clinical Research, Woolloongabba

14623

Skin Search of Rochester, Inc, Rochester

33511

Moore Clinical Research, Brandon

37922

The Skin Wellness Center, Knoxville

45040

Dermatologists of Southwest Ohio, Mason

46250

Dawes Fretzin Clinical Research, Indianapolis

78213

Progressive Clinical Research, San Antonio

91324

Quest Dermatology Research, Northridge

100029

China-Japan Friendship Hospital, Beijing

100034

Peking University First Hospital, Beijing

100044

Peking University People's Hospital, Beijing

100050

Beijing Friendship Hospital, Capital Medical University, Beijing

100730

Beijing Tongren Hospital, Capital Medical University, Beijing

110001

The First Hospital of China Medical University, Shenyang

200071

Shanghai Skin Disease Hospital, Shanghai

210029

Jiangsu Province People's Hospital, Nanjin

300120

Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin

310003

The First Affiliated Hospital of Zhejiang University, Hangzhou

310020

SIR RUN RUN Shaw Hospital Zhejiang University School of Medicine, Hangzhou

350005

The First Affiliated Hospital of Fujian Medical University, Fuzhou

400011

Chongqing Traditional Chinese medicine Hospital, Chongqing

400016

The First Affiliated Hospital of Chongqing Medical University, Chongqing

450003

Henan Provincial People's Hospital, Zhengzhou

510030

Guangdong Provincial People's Hospital, Guangzhou

Unknown

Beijing Friendship Hospital, Capital Medical University, Beijing

Beijing Tongren Hospital, Capital Medical University, Beijing

Peking University People's Hospital, Beijing

The Dermatology Hospital of Nanfang Medical University, Guangzhou

The Dermatology Hospital of Nanfang Medical University, Guangzhou

All Listed Sponsors
lead

Reistone Biopharma Company Limited

INDUSTRY

NCT04346316 - A Phase II Study in Patients With Alopecia Areata | Biotech Hunter | Biotech Hunter